Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Disease type
1.1.2. Product
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease Type Outlook
2.2.2. Product Outlook
2.2.3. Regional Outlook
2.3. Competitive Insights
Chapter 3. Pruritus Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Pruritus Therapeutics Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Pruritus Therapeutics: Disease Type Estimates & Trend Analysis
4.1. Pruritus Therapeutics Market: Key Takeaways
4.2. Pruritus Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Atopic Dermatitis
4.3.1. Atopic dermatitis market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Allergic Contact Dermatitis
4.4.1. Allergic contact dermatitis market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Urticaria
4.5.1. Urticaria market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Others
4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Pruritus Therapeutics: Product Estimates & Trend Analysis
5.1. Pruritus Therapeutics Market: Key Takeaways
5.2. Pruritus Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Corticosteroids
5.3.1. Corticosteroids market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Antihistamines
5.4.1. Antihistamines market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. Local Anesthetics
5.5.1. Local anesthetics market estimates and forecasts, 2018 to 2030 (USD Billion)
5.6. Counterirritants
5.6.1. Counterirritants market estimates and forecasts, 2018 to 2030 (USD Billion)
5.7. Immunosuppressant
5.7.1. Immunosuppressant market estimates and forecasts, 2018 to 2030 (USD Billion)
5.8. Calcineurin Inhibitors
5.8.1. Calcineurin inhibitors market estimates and forecasts, 2018 to 2030 (USD Billion)
5.9. Others
5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Pruritus Therapeutics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Pruritus Therapeutics Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.7. Middle East & Africa
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Abbvie, Inc.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Actavis Plc
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Amgen, Inc.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Astellas Pharma
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Bristol-Myers Squibb
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Cara Therapeutics
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. GlaxoSmithKline, Plc.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Myaln NV
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Novartis AG
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Pfizer Inc.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Sanofi
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Teva Pharmaceuticals
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
Table 1 List of Abbreviations
Table 2 North America pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 3 North America pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 4 North America pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 5 U.S. pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 6 U.S. pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 7 Canada pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 8 Canada pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 9 Europe pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 10 Europe pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 11 Europe pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 12 Germany pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 13 Germany pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 14 UK pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 15 UK pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 16 France pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 17 France pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 18 Italy pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 19 Italy pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 20 Spain pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 21 Spain pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 22 Sweden pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 23 Sweden pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 24 Norway pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 25 Norway pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 26 Denmark pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 27 Denmark pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 28 Asia Pacific pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 29 Asia Pacific pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 30 Asia Pacific pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 31 Japan pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 32 Japan pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 33 China pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 34 China pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 35 India pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 36 India pruritus therapeutics market, by product, (USD Billion) 2018 – 2030
Table 37 Australia pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 38 Australia pruritus therapeutics market, by product, (USD Billion) 2018 – 2030
Table 39 Thailand pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 40 Thailand pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 41 South Korea pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 42 South Korea pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 43 Latin America pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 44 Latin America pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 45 Latin America pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 46 Brazil pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 47 Brazil pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 48 Mexico pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 49 Mexico pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 50 Argentina pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 51 Argentina pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 52 Middle East and Africa pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 53 Middle East and Africa pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 54 Middle East and Africa pruritus therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 55 South Africa pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 56 South Africa pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 57 Saudi Arabia pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 58 Saudi Arabia pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 59 UAE pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 60 UAE pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
Table 61 Kuwait pruritus therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 62 Kuwait pruritus therapeutics market, by product, 2018 - 2030 (USD Billion)
